ES2055104T3 - Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap. - Google Patents

Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap.

Info

Publication number
ES2055104T3
ES2055104T3 ES89312361T ES89312361T ES2055104T3 ES 2055104 T3 ES2055104 T3 ES 2055104T3 ES 89312361 T ES89312361 T ES 89312361T ES 89312361 T ES89312361 T ES 89312361T ES 2055104 T3 ES2055104 T3 ES 2055104T3
Authority
ES
Spain
Prior art keywords
fap
preparing
procedure
compound
antagonist activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89312361T
Other languages
English (en)
Spanish (es)
Inventor
Aiya Sato
Michihiro Sugano
Kouhei Furuya
Takeshi Oshima
Harumitsu Kuwano
Tadashi Hata
Hideyuki Haruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2055104T3 publication Critical patent/ES2055104T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES89312361T 1988-11-28 1989-11-28 Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap. Expired - Lifetime ES2055104T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30027888 1988-11-28

Publications (1)

Publication Number Publication Date
ES2055104T3 true ES2055104T3 (es) 1994-08-16

Family

ID=17882866

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89312361T Expired - Lifetime ES2055104T3 (es) 1988-11-28 1989-11-28 Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap.

Country Status (7)

Country Link
US (1) US5151529A (de)
EP (1) EP0371762B1 (de)
KR (1) KR940004128B1 (de)
AT (1) ATE88707T1 (de)
CA (1) CA2003956A1 (de)
DE (1) DE68906248T2 (de)
ES (1) ES2055104T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842291A4 (de) * 1995-07-25 1998-11-11 Merck & Co Inc Inhibitoren der farnesyl-protein transferase
US5663193A (en) * 1995-07-25 1997-09-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP4123106B2 (ja) 2003-08-22 2008-07-23 ソニー株式会社 有機el素子

Also Published As

Publication number Publication date
DE68906248D1 (de) 1993-06-03
CA2003956A1 (en) 1990-05-28
EP0371762A3 (de) 1991-03-20
DE68906248T2 (de) 1993-08-12
US5151529A (en) 1992-09-29
KR940004128B1 (ko) 1994-05-13
EP0371762A2 (de) 1990-06-06
ATE88707T1 (de) 1993-05-15
KR900008048A (ko) 1990-06-02
EP0371762B1 (de) 1993-04-28

Similar Documents

Publication Publication Date Title
AR241008A1 (es) Procedimiento para el montaje de un ascensor y el ascensor obtenido por el mismo''
ES2124479T3 (es) Composiciones biocidas.
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
ATE200279T1 (de) Herstellung von 3,4,4-trisubstituiertem piperidinyl-n-alkylcarboxylaten und zwischenverbindungen, verwendbar als opioid antagonisten
EP0620251A3 (de) Mischbare Polyolefin-Mischungen.
FI921345A0 (fi) Piperidinderivat.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
ITMI920526A1 (it) Tassani di interesse oncologico, loro metodo di preparazione ed uso
EP0318084A3 (de) Benzoheterazole
SE8902076D0 (sv) Derivatives of quinoline-3-carboxanilide
ES2193246T3 (es) Cefalosporinas antibacterianas.
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
FI941776A7 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
UA27713C2 (uk) Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
PT91203A (pt) Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem
ES2055104T3 (es) Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap.
ES2046178T3 (es) Metodo de uso de diltiazen, verapamil o nifedipina que presentan actividad para el tratamiento de ataques de apoplejia.
EP0116150A3 (de) Pharmazeutisch aktive heterozyklische Verbindungen mit mindestens vier Ring-Stickstoffatomen, deren Herstellung und Fermentationsbrühe von ASPERGILLUS ALLIACEUS ATCC 20655 und 20656
EA199800889A1 (ru) Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE69006931D1 (de) Ghilanten: antimetastatischer Wirkstoff aus dem südamerikanischen Blutegel Haementeria Ghilianii.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
NO963791L (no) Peptidderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 371762

Country of ref document: ES